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Widespread availability of HAART has dramatically
decreased rates of AIDS-related diseases and death since
1996, among those engaged in care. The overall success of
HAART, however, has been limited because of uneven
access to therapy among various groups of HIV infected
individuals. In BC, despite a universal health care system
(which includes the provision of antiretrovirals free of
charge), HAART coverage remains suboptimal among
young men who have sex with men (MSM), Aboriginal
individuals, the homeless, the poor, the mentally ill, and
injection drug users (IDUs). As a result, marginalized and
hard-to-reach individuals continue to bear a dispropor-
tionate burden of HIV/AIDS related morbidity and mor-
tality in the province. More recently, strong evidence has
become available indicating that HAART can impact
transmission of HIV. In brief, HAART rapidly and effec-
tively renders HIV undetectable in blood and genital
secretions and this is associated with decreased risk of
transmission. We recently developed a mathematical
model to predict the potential impact of expanding
HAART coverage among those in medical need on the
spread of HIV in BC. The model used data on the natural
history of HIV infection, risk factors, HIV-1 RNA and CD4
cell counts, and the sources of transmission to derive the
probable incidence of HIV in the coming years. Based on
the available BC data, the model indicates that the status
quo (i.e. initiation of HAART at CD4 counts of 200 cells/
mm3 or less, with coverage levels of 50% of those in med-
ical need, and current compliance levels of 78.5%) will
result in a continued 10% annual increase in new HIV
cases. In contrast, the model predicts that an increase in
HAART coverage to 75%, 90% and 100% of those in med-
ical need would result in a decline in the annual incidence
of new HIV cases by 37%, 54% and 62%, respectively,
resulting in very significant savings over the long term.
Therefore, the BC-CfE proposes to expand HAART cover-
age in BC specifically among hard-to-reach HIV-infected
individuals. This program labelled "Seek and Treat for
Optimal Prevention of HIV & AIDS" (STOP HIV & AIDS),
will aim to decrease AIDS-related diseases and death
among those already infected with HIV and to decrease
the emergence of new HIV infections in BC. Lessons
learned from this initiative should assist in the develop-
ment of public health policy aimed to expand HAART
coverage with the dual goal of decreasing AIDS-related
morbidity and mortality and assisting traditional preven-
tion efforts aimed to reduce HIV incidence.
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